Zoetis
ZTS
$1.06 (-1.37%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 6 hours ago • ZTS
Gear Up for Zoetis (ZTS) Q2 Earnings: Wall Street Estimates for Key Metrics
Zacks Investment Research • 1 day ago • ZTS
ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect
Zacks Investment Research • 5 days ago • ZTS
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Zacks Investment Research • 8 days ago • ZTS
Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.